Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study

Author： Zerbini C.   Ozturk Z. E.   Grifka J.   Maini M.   Nilganuwong S.   Morales R.   Hupli M.   Shivaprakash M.   Giezek H.    

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.12, 2005-12, pp. : 2037-2049

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

By Colonna Lucien   Andersen Henning Friis   Reines Elin Heldbo  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1659-1668

Informa Healthcare

Access to resources Recommend Favorite

Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 72, Iss. 2, 2018-02 ,pp. : 64-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Day‐to‐Day Changes of Auricular Point Acupressure to Manage Chronic Low Back Pain: A 29‐day Randomized Controlled Study

By  

PAIN MEDICINE, Vol. 16, Iss. 10, 2015-10 ,pp. : 1857-1869

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Thermal Water and Adjunctive Electrotherapy on Chronic Low Back Pain: A Double-Blind, Randomized, Follow-up Study

By Kulisch Ágota   Bender Tamás   Németh András   Szekeres László  

Journal of Rehabilitation Medicine, Vol. 41, Iss. 1, 2009-01 ,pp. : 73-79

Medical Journals Limited

Access to resources Recommend Favorite

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder*

By Liebowitz Michael R.   Manley Amy L.   Padmanabhan Sudharshan K.   Ganguly Rita   Tummala Raj   Tourian Karen A.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1877-1890

Informa Healthcare

Access to resources Recommend Favorite